What are the side effects of bendamustine?

FAQ Library published on August 2, 2012 in Comorbidities/SEs
Download Transcript
Sergio A. Giralt, MD, FACP
Melvin Berlin Family Chair in Myeloma Research
Professor of Medicine
Weill Cornell Medical College
Chief Attending Physician
Adult Bone Marrow Transplant Service
Memorial Sloan Kettering Cancer Center
New York, New York

This is Dr. Sergio Giralt from Memorial Sloan-Kettering Cancer Center answering frequently asked questions regarding bendamustine.

I am frequently asked, “What are the side effects of bendamustine?” Bendamustine is currently available for the treatment of lymphoid malignancies, particularly chronic lymphocytic leukemia but it also can be used for multiple myeloma. It can only be administered intravenously and it is usually given over one or two days. It is associated with decreases in white count, platelet count, and red count. It may cause nausea, vomiting, weight loss, or diarrhea. It is important that bendamustine be administered under the supervision of an expert physician.

Reviewed on January 17, 2017 for clinical relevance.

Last modified: February 8, 2017
Related Items by Category
How can you ensure patients are reporting side effects?
FAQ Library published on May 9, 2013 in Response Assessment, Comorbidities/SEs
How do I manage the side effects of stem cell transplantation?
FAQ Library published on January 9, 2013 in Stem Cell Transplant, Comorbidities/SEs
What are the common side effects of melphalan?
FAQ Library published on August 30, 2012 in Comorbidities/SEs
What are the common side effects of bortezomib?
FAQ Library published on August 23, 2012 in Comorbidities/SEs
What are the most common side effects of pomalidomide?
FAQ Library published on August 16, 2012 in Comorbidities/SEs
What are the most common side effects of carfilzomib?
FAQ Library published on August 9, 2012 in Comorbidities/SEs
What are the most common side effects of lenalidomide therapy?
FAQ Library published on July 26, 2012 in Comorbidities/SEs, Nurses & Pharmacists
What are the common side effects of histone deacetylase (HDAC) inhibitors?
FAQ Library published on July 26, 2012 in Comorbidities/SEs, Nurses & Pharmacists
What are the common side effects of dexamethasone?
FAQ Library published on July 13, 2012 in Comorbidities/SEs, Nurses & Pharmacists
What therapy side effects are most common in elderly patients?
FAQ Library published on November 7, 2011 in Comorbidities/SEs, Treating Elderly
Related Items by Author
Should I wait for the development of CRAB prior to initiating therapy in multiple myeloma patients?
Sergio A. Giralt, MD, FACP
FAQ Library published on October 11, 2016
What are the new NCCN/IMWG recommended baseline workup tests for multiple myeloma?
Sergio A. Giralt, MD, FACP
FAQ Library published on August 3, 2016
Will new MM diagnostic criteria cause confusion in risk stratifying smoldering and active myeloma?
Sergio A. Giralt, MD, FACP
FAQ Library published on June 7, 2016
What have we learned about the timing of transplant for newly diagnosed MM patients?
Sergio A. Giralt, MD, FACP
FAQ Library published on December 18, 2014
How do I manage the side effects of stem cell transplantation?
Sergio A. Giralt, MD, FACP
FAQ Library published on January 9, 2013 in Stem Cell Transplant, Comorbidities/SEs
Which patients do you consider for delayed transplantation?
Sergio A. Giralt, MD, FACP
FAQ Library published on January 9, 2013 in Stem Cell Transplant
What are the common side effects of melphalan?
Sergio A. Giralt, MD, FACP
FAQ Library published on August 30, 2012 in Comorbidities/SEs
What are the most common side effects of lenalidomide therapy?
Sergio A. Giralt, MD, FACP
FAQ Library published on July 26, 2012 in Comorbidities/SEs, Nurses & Pharmacists
How do I address concerns for patients who “refuse” stem cell transplantation?
Sergio A. Giralt, MD, FACP
FAQ Library published on September 26, 2011 in Stem Cell Transplant, Patient Communication
Is there a subset of patients that would benefit from delayed SCT?
Sergio A. Giralt, MD, FACP
FAQ Library published on September 8, 2011 in Stem Cell Transplant